We are trusted by cardiologists with their most challenging needs.
We can't wait to help you with yours.
WE UNDERSTAND CLINICAL WORKFLOWS IN DIAGNOSTIC CARDIOLOGY.
It’s why cardiologists like you have trusted us with their most challenging needs for more than 30 years.
We have a long-standing relationship with the U.S. Food and Drug Administration (FDA), providing ECG algorithm tools and data warehousing solutions to support the Agency's regulatory review of cardiac safety data. Digital ECGs acquired in cardiac safety studies are submitted to the FDA ECG Warehouse for storage, analysis and review.
In 2004, the FDA selected us to create their ECG Warehouse based on our ability to meet their requirements, and because of the power of the VERITAS® ECG algorithm to automate the analysis and scoring of the vast amount of data presented.1
Today, the FDA ECG Warehouse is the largest digital ECG repository—it contains over 9,7 million ECGs from more than 500 QT studies2, all of which have been automatically analyzed by the VERITAS algorithm.
We have delivered tens of thousands of ELI™ ECG devices to the pharmaceutical industry, which have acquired millions of ECGs to assess cardiac risk for new drugs in development.
We can proudly say that each of the top 20 pharmaceutical companies in the world have chosen ELI devices equipped with the VERITAS algorithm for their clinical trials.
This makes VERITAS a leading algorithm used in clinical trials requiring digital ECG and the preferred solution used by all leading central ECG laboratories.3
NASA trusts our Holter solutions in research studies on the effects of long-term space travel on cardiac functions and blood vessels.4
We helped NASA to collect ECG information from astronauts working in the International Space Station under extreme conditions. Collected ECG data was then sent via satellite and analyzed at the Johnson Space Center in Houston, Texas (U.S.) generating reports comparing results with those of other studies.
We can’t wait to start working with you!
Let us know your challenges.
We help you to deliver comprehensive cardiac care with an efficient workflow across
the continuum of care.
DEVICES CONNECT TO A NUMBER OF SYSTEMS:
EMR, PACS, CVIS, ECG MANAGEMENT...
VERITAS (Latin for “Truth”) is our name for the advanced ECG algorithm used to measure and interpret ECG waveform data.
Today, and for over 30 years, VERITAS has been continuously developed and enhanced to include measurement, interpretation and decision support criteria for multiple ECG related modalities.
Have you ever listened to a poor recording of your favorite song? Recording an ECG has many similarities with recording music.
We guarantee a superior transcription of the ECG signals from the patient to the printout. We have invested heavily in our technology to be the world-renowned provider of signal acquisition technology.
Because you needed freedom of movement and flexibility, in 2010 we launched for the first time a 12-lead wireless patient cable for resting ECG.
Use the WAM Wireless Acquisition Module to free your care area from unnecessary wires and make your patients more comfortable at the same time.
* In 1992 we launched the X12, the first wireless patient cable for resting ECG.
Issues with patient compliance? No problem. The H3+TM Digital Holter Recorder is so small, patients will hardly notice it’s there.
The H3+ Recorder is one of the smallest and lightest 3-channels Holter recorders currently on the market that also supports continuous recording for up to seven days with one common (AAA) battery.
Sources:
1 - Sarapa N, Mortara JL, Brown BD, Isola L, Badilini F. Quantitative performance of E-Scribe warehouse in detecting quality issues with digital annotated ECG data from healthy subjects. J Clin Pharmacol. 2008 May;48(5):538-46. doi: 10.1177/0091270008316326. Epub 2008 Mar 19. PubMed PMID: 18353997.
2 - FDA Briefing Document “Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting” March 15, 2017
3 - Stergiopoulos S, Feldman L, Getz KA. White paper: “Mapping adoption of centralized cardiac safety assessment: report on the results of a study conducted by the Tufts Center for the Study of Drug Development (Tufts CSDD)”. Boston: Tufts Center for the Study of Drug Development. March 2010. 2010.
4 - NASA, www.nasa.gov/mission_pages/station/research/experiments/2207.h
The WAM (wireless acquisition module) must be paired to electrocardiograph before operation and it’s indicated for use as a radiofrequency physiological signal transmitter that acquires and delivers RF transmission of electrocardiographic data obtained during resting/physiologic electrocardiographic testing. Indicated for use in a clinical setting, by qualified medical professionals, properly trained for acquiring ECG data of patients of any age. The H3+ Digital Holter Recorder is indicated for use in a clinical setting, by qualified medical professionals only, for recording ECG data of adult patients requiring ambulatory (Holter) monitoring. Medical devices (93/42/EEC): Class IIa. Notified Body: LNE/G-MED (CE0459) Manufacturer: Mortara Instrument, Inc., Milwaukee, Wisconsin U.S.A. EC Rep.: Mortara Instrument Europe, Srl, Via Cimarosa 103-105, 40033 Casalecchio di Reno (BO), Italy. These medical devices are a regulated health product which, pursuant to such regulation bears a CE mark. Carefully read the detailed instructions for safe and proper use included in the documents accompanying the medical devices. The personnel of healthcare establishments are responsible for the proper use and maintenance of these medical devices. Welch Allyn Inc. reserves the right to make changes without notice in design, specifications and models. The only warranty Welch Allyn Inc. makes is the express written warranty extended on the sale of its products.
© 2019 Welch Allyn Inc. ALL RIGHTS RESERVED. MC16008-EN-R0 2019-07